Delivery Order SPE2DB22D1202-SPE2DB25FVGM5
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,360.45 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $3,938.77 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pens on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award for pharmaceutical supply to support federal medical procurement needs. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and the product will be delivered under...
- The Defense Logistics Agency awarded a $1,360.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This contract was awarded competitively with no set-aside designation and has an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under a larger procurement vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies on August 7, 2025, with completion targeted for August 8, 2025. This firm fixed-price delivery order, valued at $9,449.50, covers the supply of Mounjaro 5 mg/0.5 mL pens in 0.5 mL quantities. The award was issued on a non-set-aside basis through open competition, reflecting AmerisourceBergen's demonstrated capability to meet federal procurement standards. Performance will take...
- The Defense Logistics Agency awarded a delivery order valued at $2,586.22 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This firm fixed-price delivery order is non-competitive and utilizes a competitively awarded indefinite delivery contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. As a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Mounjaro 10 mg/0.5 mL pens, with a ceiling value of $11,775.62. This firm fixed-price delivery order was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, and represents a competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,904.63 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, executed without set-aside designation, represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The product will be delivered to the same location, supporting the federal government's medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Mounjaro 10 mg/0.5 ml pens in 0.5 ml doses. This firm fixed-price delivery order, valued at $2,720.90, represents a non-competitive award to the contractor's Conshohocken, Pennsylvania facility and is scheduled for completion by August 6, 2025. The order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $7,186.32 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract involves no set-aside designation and represents a continuation of the company's role as a critical...
- The Defense Logistics Agency awarded a $2,360.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on July 25, 2025, with a completion date of July 28, 2025. This non-competitive delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the Department of Defense medical supply chain. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVGM5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,460.99 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pens on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award under DLA's pharmaceutical supply chain. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and related medical commodities. The contract supports multiple federal customers including the Defense Health Agency and U.S. Coast Guard, demonstrating AmerisourceBergen Drug Corp's critical role as a major pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 8/5/25 |